# Intuitive Surgical, Inc. (ISRG) FY2026 Q2 Balance Sheet

- Company: Intuitive Surgical, Inc. (ISRG)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-21, accession number 0001035267-26-000058
- Page: https://plicit.ai/financials/isrg/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/isrg-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 20,876,600,000 US dollars
- **Current assets**: 9,542,700,000 US dollars
- **Non-current assets**: 11,333,900,000 US dollars
- **Liabilities**: 2,578,900,000 US dollars
- **Current liabilities**: 1,922,900,000 US dollars
- **Non-current liabilities**: 656,000,000 US dollars
- **Equity**: 18,297,700,000 US dollars
- **Noncontrolling interest**: 129,300,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Cash and cash equivalents**: 2,760,400,000 US dollars
- **Short-term investments**: 2,455,800,000 US dollars
- **Inventory**: 2,028,700,000 US dollars
- **Accounts receivable, net**: 1,673,200,000 US dollars
- **Prepaids and other current assets**: 624,600,000 US dollars
- **Property, plant, and equipment, net**: 5,551,500,000 US dollars
- **Long-term investments**: 3,409,300,000 US dollars
- **Intangible and other assets, net**: 1,140,100,000 US dollars
- **Deferred tax assets**: 652,400,000 US dollars
- **Goodwill**: 580,600,000 US dollars
- **Other accrued liabilities**: 670,600,000 US dollars
- **Deferred revenue**: 549,400,000 US dollars
- **Accrued compensation and employee benefits**: 425,700,000 US dollars
- **Accounts payable**: 277,200,000 US dollars
- **Other long-term liabilities**: 656,000,000 US dollars
- **Additional paid-in capital**: 11,325,000,000 US dollars
- **Retained earnings**: 6,837,200,000 US dollars
- **Accumulated other comprehensive income**: 5,800,000 US dollars
- **Common stock, 600.0 shares authorized, $0.001 par value, 353.9 shares and 355.1 shares issued and outstanding as of June 30, 2026, and December 31, 2025, respectively**: 400,000 US dollars
- **Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of June 30, 2026, and December 31, 2025**: 0 US dollars
- **Noncontrolling interest in joint venture**: 129,300,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.